Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Gail

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Controlled Clinical Trials|December 1, 1982
Monitoring rules for stopping accrual in comparative survival studiesL V Rubinstein, M H Gail
Clinical Chemistry|April 1, 1991
Predicting AIDS onset for individual patientsJ J Goedert, M H Gail
Experimental Cell Research|July 1, 1972
Procaine inhibition of fibroblast motility and proliferationM H Gail, C W Boone
Experimental Cell Research|September 1, 1971
Cytochalasin effects on BALB-3T3 fibroblasts: dose-dependent, reversible alteration of motility and cytoplasmic cleavageM H Gail, C W Boone
Journal of the National Cancer Institute. Monographs|June 16, 2000
Kin-cohort designs for gene characterizationM H Gail, D Pee, R Carroll
Statistics in Medicine|January 1, 1989
Disease prevention models of voluntary confidential screening for human immunodeficiency virus (HIV)M H Gail, D Preston, S Piantadosi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Graphs to estimate an individualized risk of breast cancerJ Benichou, M H Gail, J J Mulvihill
Journal of the National Cancer Institute|August 1, 1985
Screening geographic areas for unusual survival experience or stage at diagnosis with application to breast and colon cancerS Piantadosi, D P Byar, M H Gail
American Journal of Epidemiology|July 1, 1987
The prevalent cohort study and the acquired immunodeficiency syndromeR Brookmeyer, M H Gail, B F Polk
American Journal of Industrial Medicine|January 1, 1988
Indirect corrections for confounding under multiplicative and additive risk modelsM H Gail, S Wacholder, J H Lubin
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Controlled Clinical Trials|December 1, 1982
Monitoring rules for stopping accrual in comparative survival studiesL V Rubinstein, M H Gail
Clinical Chemistry|April 1, 1991
Predicting AIDS onset for individual patientsJ J Goedert, M H Gail
Experimental Cell Research|July 1, 1972
Procaine inhibition of fibroblast motility and proliferationM H Gail, C W Boone
Experimental Cell Research|September 1, 1971
Cytochalasin effects on BALB-3T3 fibroblasts: dose-dependent, reversible alteration of motility and cytoplasmic cleavageM H Gail, C W Boone
Journal of the National Cancer Institute. Monographs|June 16, 2000
Kin-cohort designs for gene characterizationM H Gail, D Pee, R Carroll
Statistics in Medicine|January 1, 1989
Disease prevention models of voluntary confidential screening for human immunodeficiency virus (HIV)M H Gail, D Preston, S Piantadosi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Graphs to estimate an individualized risk of breast cancerJ Benichou, M H Gail, J J Mulvihill
Journal of the National Cancer Institute|August 1, 1985
Screening geographic areas for unusual survival experience or stage at diagnosis with application to breast and colon cancerS Piantadosi, D P Byar, M H Gail
American Journal of Epidemiology|July 1, 1987
The prevalent cohort study and the acquired immunodeficiency syndromeR Brookmeyer, M H Gail, B F Polk
American Journal of Industrial Medicine|January 1, 1988
Indirect corrections for confounding under multiplicative and additive risk modelsM H Gail, S Wacholder, J H Lubin
Pageof 15